Healthpeak Properties Stock (US42226K1051): analyst upgrade and ex-dividend date put income REIT in focus

Healthpeak Properties shares are in focus as BMO Capital lifts its price target and the healthcare REIT trades ex-dividend for its latest monthly payout, keeping the NYSE-listed stock on the radar of US income investors.

Responsible: ad hoc news Stocks & Analysis Desk. Reviewed prior to publication on June 15, 2026 at 5:04 PM ET. Details in the imprint.

Healthpeak Properties is back in focus for US income investors as the healthcare real estate investment trust combines a fresh analyst price target increase with its latest ex-dividend date on the New York Stock Exchange. According to MarketScreener data, the stock most recently closed at $20.69 on the NYSE under the ticker DOC, with an average analyst target around $21.06, underscoring modest implied upside in current consensus expectations. At the same time, the REIT, which focuses on healthcare discovery and delivery properties across the United States, continues to attract attention for its monthly dividend stream and above-average yield profile.

BMO Capital lifts Healthpeak price target while maintaining positive rating

A key near-term trigger for Healthpeak Properties this week comes from analyst research. BMO Capital has raised its price target on the stock to $24 from $20 while reiterating an "Outperform" rating, according to a note cited by The Fly and MarketScreener. That new target sits materially above both the stock's latest closing price near $20.69 and the broader analyst average target around $21.06 reported by MarketScreener, signaling that BMO sees room for further upside compared with the current consensus view. In practical terms, the $24 target implies roughly mid-teens percentage upside from the latest share price level, although actual returns will depend on market conditions and company performance.

The BMO move comes against a backdrop where, according to MarketBeat, Healthpeak Properties carries an overall average rating of "Hold" across covering analysts, with an average price target of approximately $19.54 in that dataset. That difference underscores how individual firms can diverge in their assessment of valuation and risk, with BMO clearly more constructive than the consensus indicated by MarketBeat's compilation. For investors comparing sources, the varying average target figures highlight the importance of understanding which analyst universe each data provider includes and how frequently those numbers are updated.

While BMO's detailed reasoning is shared as part of a broader healthcare REIT review, its decision to both raise the target and maintain an Outperform stance suggests confidence in Healthpeak's portfolio, balance sheet, or cash flow prospects relative to peers. As a fully integrated healthcare-focused REIT, the company acquires, develops, owns, leases, and manages properties linked to healthcare discovery and delivery, positioning it in segments like medical office buildings, life science facilities, and senior or post-acute care assets across the United States. Such assets are typically underpinned by long-term leases and tenant relationships that can provide visibility on rental income, though they also expose the REIT to sector-specific regulatory and reimbursement risks.

Another recent data point on the institutional side comes from MarketBeat reporting that Resources Management Corp CT ADV sharply increased its stake in Healthpeak Properties in the fourth quarter. According to that filing-based summary, the firm boosted its holdings by about 1,129.2 percent, adding roughly 79,210 shares to reach a total of approximately 86,220 shares of Healthpeak. While this is only one manager among many, such a large percentage increase in position size can signal growing conviction at that particular investor, though it does not necessarily reflect the stance of the broader institutional holder base.

Beyond BMO's upgrade, Healthpeak's profile as an income-oriented stock remains central to how the market views it. A recent analysis highlighted the company as one of the higher-yield healthcare names, noting that at prevailing prices Healthpeak offers a forward dividend yield around 7.1 percent and pays its dividend on a monthly schedule. For US retail investors who prioritize regular cash distributions, that combination of elevated yield and monthly frequency can be attractive compared with quarterly payers, particularly within the healthcare property segment where cash flows are often tied to demographic trends like aging populations and demand for medical services.

Current dividend activity provides another near-term reference point. Swedish outlet Placera, citing FactSet, reported that Healthpeak shares are trading ex-dividend today for a distribution of $0.102 per share. The ex-dividend date marks the point at which new buyers are no longer entitled to the upcoming payout and is often accompanied by a mechanical adjustment in the share price roughly equal to the dividend amount. For a stock priced around the low $20s, a roughly ten-cent monthly dividend aligns with the previously cited forward yield in the mid-single-digit to low-double-digit range, though yield will fluctuate with the share price over time.

MarketScreener characterizes Healthpeak as a fully integrated REIT that owns and manages healthcare real estate across the United States, with operations focused on assets supporting both healthcare discovery and delivery. This positioning sets the company within a specialized corner of the real estate market, distinct from more generalist REITs that own offices, retail centers, or industrial warehouses. Healthcare-focused REITs often emphasize long-term leases with hospital systems, physician groups, and research organizations, which can potentially provide durable occupancy and rent collections, but they also face exposure to healthcare policy shifts, reimbursement frameworks, and changes in care delivery models.

Valuation metrics and index inclusion also matter for investor positioning. While detailed multiples were not highlighted in the latest search results, MarketScreener data indicate that Healthpeak trades on the NYSE and is part of the broader US real estate universe, with recent performance figures showing a gain of roughly 28 percent over a longer comparative period alongside more modest short-term moves. The presence of an average target near $21.06 next to a last close around $20.69 suggests that, at least on MarketScreener's numbers, the stock trades fairly close to the median analyst view, which can limit implied upside from current levels unless earnings or cash flow trends outperform expectations.

From a sector standpoint, the company competes and is compared with other healthcare REITs such as National Health Investors, which has also been discussed in recent analysis pieces as potentially underappreciated by the market. Such cross-comparisons often look at metrics like funds from operations (FFO), dividend payout ratios, leverage, and tenant diversification. While specific Healthpeak FFO or payout ratio data were not included in the retrieved sources, investors will typically judge the sustainability of its monthly dividend and its capacity for growth against similar healthcare and senior housing landlords, as well as against more diversified REITs that may offer different risk-return trade-offs.

For now, the combination of an upwardly revised price target from BMO Capital, a fresh ex-dividend date with a $0.102 per share payout, and an elevated forward yield around 7.1 percent keeps Healthpeak Properties squarely on the radar of investors who focus on income from the healthcare real estate segment. How the stock trades in the coming sessions will likely depend on broader moves in interest rates, sentiment toward REITs, and any further signals on portfolio performance or capital allocation from company communications such as its investor relations materials on the Healthpeak website at healthpeak.com.

Healthpeak Properties at a glance

• Name: Healthpeak Properties, Inc.
• Industry: Healthcare real estate investment trust (REIT)
• Headquarters: Denver, Colorado, United States
• Core markets: Healthcare discovery and delivery properties across the United States
• Revenue drivers: Rental income from medical office, life science, and other healthcare-focused properties
• Listing: NYSE, ticker symbol DOC
• Trading currency: US dollars (USD)

This article was created with a.i. assistance and editorially reviewed. Not investment advice, not a buy or sell recommendation. Trading in securities carries risks up to the total loss of capital.